Cystic Fibrosis Trust Profile picture
We're dedicated to uniting for a #lifeunlimited for those living with #cysticfibrosis. Our social & Helpline teams monitor our accounts between 9-5 weekdays.
Nov 3, 2023 7 tweets 2 min read
NICE have today given an update on their evaluation of the cost-effectiveness of the modulator drugs Kaftrio, Orkambi and Symkevi.

➡️ (1/7) ow.ly/h4JG50Q3POq
NICE have today given an update on their evaluation of the cost-effectiveness of the modulator drugs Kaftrio, Orkambi and Symkevi. They have confirmed they are highly effective for people with cystic fibrosis, however, have judged that they are too expensive at the current price for them to recommend full access on the NHS. They have confirmed they are highly effective for people with #cysticfibrosis, however, have judged that they are too expensive at the current price for them to recommend full access on the NHS. (2/7)
Nov 17, 2022 7 tweets 2 min read
In response to @Jeremy_Hunt's #AutumnStatement, David Ramsden, Chief Executive of Cystic Fibrosis Trust, said: "Many people with #cysticfibrosis are in a desperate situation and face a very challenging winter." (1/7) "While it is a relief that the Chancellor has responded to our call for benefits to be increased in line with inflation, this increase needs to be implemented immediately, rather than waiting until April 2023." (2/7)